These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38780075)

  • 1. Moving Beyond Antibiotics: Exploring the Potential of an Antivirulence Monoclonal Antibody against
    Crabbé A
    Am J Respir Crit Care Med; 2024 Jul; 210(1):8-9. PubMed ID: 38780075
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrolides for the treatment of Pseudomonas aeruginosa infections?
    Howe RA; Spencer RC
    J Antimicrob Chemother; 1997 Aug; 40(2):153-5. PubMed ID: 9301978
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
    Suarez-Cuartin G; Smith A; Abo-Leyah H; Rodrigo-Troyano A; Perea L; Vidal S; Plaza V; Fardon TC; Sibila O; Chalmers JD
    Respir Med; 2017 Jul; 128():1-6. PubMed ID: 28610665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colistin inhalation helps against Pseudomonas aeruginosa,].
    Reinhardt D
    MMW Fortschr Med; 2014 Nov; 156(20):40. PubMed ID: 25543364
    [No Abstract]   [Full Text] [Related]  

  • 5. A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of
    Long MB; Gilmour A; Kehl M; Tabor DE; Keller AE; Warrener P; Gopalakrishnan V; Rosengren S; Crichton ML; McIntosh E; Giam YH; Keir HR; Brailsford W; Hughes R; Belvisi MG; Sellman BR; DiGiandomenico A; Chalmers JD
    Am J Respir Crit Care Med; 2024 Jul; 210(1):35-46. PubMed ID: 38754132
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa: resistance and therapy.
    Cunha BA
    Semin Respir Infect; 2002 Sep; 17(3):231-9. PubMed ID: 12226802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report.
    Bermudez LE
    Braz J Med Biol Res; 1986; 19(2):159-65. PubMed ID: 3103793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion of Haemophilus influenzae and Pseudomonas aeruginosa in humans.
    Suzuki H; Juwono SS; Matsumoto K
    Tohoku J Exp Med; 1985 May; 146(1):105-17. PubMed ID: 3927515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate.
    Kajihara KK; Pantua H; Hernandez-Barry H; Hazen M; Deshmukh K; Chiang N; Ohri R; Castellanos ER; Martin L; Matsumoto ML; Payandeh J; Storek KM; Schneider K; Smith PA; Koehler MFT; Tsai SP; Vandlen R; Loyet KM; Nakamura G; Pillow T; Seshasayee D; Kapadia SB; Hazenbos WLW
    mBio; 2021 Jun; 12(3):e0020221. PubMed ID: 34061593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized colistin for non-cystic fibrosis bronchiectasis: déjà vu all over again?
    Metersky ML; O'Donnell AE
    Am J Respir Crit Care Med; 2014 May; 189(10):1151-2. PubMed ID: 24754731
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
    Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa.
    Dhar R; Anwar GA; Bourke SC; Doherty L; Middleton P; Ward C; Rutherford RM
    Thorax; 2010 Jun; 65(6):553. PubMed ID: 20522858
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis.
    Mudgil U; Khullar L; Chadha J; Prerna ; Harjai K
    Microb Pathog; 2024 Aug; 193():106730. PubMed ID: 38851361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAP deficiency is also a cause of bronchiectasis.
    Zimmer J; Sleiman M; Poli A; Michel T; Hentges F
    Thorax; 2013 May; 68(5):490-1. PubMed ID: 23299963
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
    Wilson R; Aksamit T; Aliberti S; De Soyza A; Elborn JS; Goeminne P; Hill AT; Menendez R; Polverino E
    Respir Med; 2016 Aug; 117():179-89. PubMed ID: 27492530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
    Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors' response to 'TAP deficiency is also a cause of bronchiectasis'.
    Whitters D; Stockley RA
    Thorax; 2013 May; 68(5):491. PubMed ID: 23717829
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic-resistant
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
    Haworth CS; Foweraker JE; Wilkinson P; Kenyon RF; Bilton D
    Am J Respir Crit Care Med; 2014 Apr; 189(8):975-82. PubMed ID: 24625200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa.
    Gramegna A; Narayana JK; Amati F; Stainer A; Wu B; Morlacchi LC; Segal LN; Tsaneva-Atanasova K; Marchisio P; Chotirmall SH; Blasi F; Aliberti S
    Chest; 2023 Jul; 164(1):65-68. PubMed ID: 36803648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.